JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandyam, C. D.
Right arrow Articles by Standifer, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandyam, C. D.
Right arrow Articles by Standifer, K. M.

Vol. 302, Issue 2, 502-509, August 2002

Orphanin FQ/Nociceptin-Mediated Desensitization of Opioid Receptor-Like 1 Receptor and µ Opioid Receptors Involves Protein Kinase C: A Molecular Mechanism for Heterologous Cross-Talk

Chitra D. Mandyam, Deepak R. Thakker, Jennifer L. Christensen and Kelly M. Standifer

Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, Texas

Morphine tolerance in vivo is reduced following blockade of the orphanin FQ/nociceptin (OFQ/N)/opioid receptor-like 1 (ORL1) receptor system, suggesting that OFQ/N contributes to the development of morphine tolerance. We previously reported that a 60-min activation of ORL1 receptors natively expressed in BE(2)-C cells desensitized both µ and ORL1 receptor-mediated inhibition of cAMP. Investigating the mechanism(s) of OFQ/N-mediated µ and ORL1 receptor cross-talk, we found that pretreatment with the protein kinase C inhibitor, chelerythrine chloride (1 µM), blocked OFQ/N-mediated homologous desensitization of ORL1 and heterologous desensitization of µ opioid receptors. Furthermore, depletion of PKC by 12-O-tetradecanoylphorbol-13-acetate exposure (48 h, 1 µM) also prevented OFQ/N-mediated µ and ORL1 desensitization. OFQ/N pretreatment resulted in translocation of PKC-alpha , G protein-coupled receptor kinase 2 (GRK2) and GRK3 from the cytosol to the membrane, and this translocation was also blocked by chelerythrine. Reduction of GRK2 and GRK3 levels by antisense, but not sense DNA treatment blocks ORL1 and µ receptor desensitization. This suggests that PKC-alpha is required for GRK2 and GRK3 translocation to the membrane, where GRK can inactivate ORL1 and µ opioid receptors upon rechallenge with the appropriate agonist. Our results demonstrate for the first time the involvement of conventional PKC isozymes in OFQ/N-induced µ-ORL1 cross-talk, and represent a possible mechanism for OFQ/N-induced anti-opioid actions.

0022-3565/02/3022-0502$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
H. Z. Ozsoy, D. R. Thakker, and K. M. Standifer
Orphanin FQ/Nociceptin Potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-Enkephalin-Induced {micro}-Opioid Receptor Phosphorylation
Mol. Pharmacol., August 1, 2005; 68(2): 447 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
G.-x. Xie and P. P. Palmer
RGS Proteins: New Players in the Field of Opioid Signaling and Tolerance Mechanisms
Anesth. Analg., April 1, 2005; 100(4): 1034 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. P. Bailey, E. Kelly, and G. Henderson
Protein Kinase C Activation Enhances Morphine-Induced Rapid Desensitization of {micro}-Opioid Receptors in Mature Rat Locus Ceruleus Neurons
Mol. Pharmacol., December 1, 2004; 66(6): 1592 - 1598.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. F. Zaratin, G. Petrone, M. Sbacchi, M. Garnier, C. Fossati, P. Petrillo, S. Ronzoni, G. A. M. Giardina, and M. A. Scheideler

J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 454 - 461.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. D. Mandyam, D. R. Thakker, and K. M. Standifer
{micro}-Opioid-Induced Desensitization of Opioid Receptor-Like 1 and {micro}-Opioid Receptors: Differential Intracellular Signaling Determines Receptor Sensitivity
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 965 - 972.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. L. Hauger, J. A. Olivares-Reyes, S. Braun, K. J. Catt, and F. M. Dautzenberg
Mediation of Corticotropin Releasing Factor Type 1 Receptor Phosphorylation and Desensitization by Protein Kinase C: A Possible Role in Stress Adaptation
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 794 - 803.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.